1,4-dihydropyridine has been researched along with Disease Models, Animal in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, H; Kim, YS; Koh, SH; Lee, KY; Lee, YJ; Park, HH; Son, JW; Yoo, A | 1 |
| Bálind, Á; Balogh, G; Bernáth, S; Blundell, KL; Frank, Z; Fülöp, F; Hooper, PL; Horváth, I; Hunya, Á; Kasza, Á; Penke, B; Prodromou, C; Sántha, M; Török, Z; Vigh, L; Zeiler, HJ | 1 |
| Beitnere, U; Jansone, B; Kadish, I; Klusa, V; Pajuste, K; Plotniece, A; van Groen, T | 1 |
| Beuhler, MC; Kerns, WP; Murphy, CM; Nicholson, B; Quinn, ME; Shoe, T; Williams, C | 1 |
| Yamamura, A | 1 |
| Bergeron, R; Chapman, KT; Ellsworth, KP; Geissler, WM; Harris, G; Myers, RW; Ogawa, AK; Willoughby, CA; Yao, J | 1 |
| Honda, A; Ishiguro, M; Russell, SR; Tranmer, BI; Wellman, GC; Wellman, TL | 1 |
| Rao, MR; Xu, Y | 1 |
| Devereux, RB; Palmieri, V | 1 |
| Rudin, M; Sauter, A | 1 |
| Bacciottini, L; Carlà, V; Moroni, F; Pellegrini-Giampietro, DE | 1 |
2 review(s) available for 1,4-dihydropyridine and Disease Models, Animal
| Article | Year |
|---|---|
Molecular Mechanism of Dihydropyridine Ca
Topics: Animals; Calcium; Calcium Channel Blockers; Calcium Signaling; Dihydropyridines; Disease Models, Animal; Disease Progression; Humans; Hypertension, Pulmonary; Molecular Targeted Therapy; Muscle, Smooth, Vascular; Nicardipine; Pulmonary Artery; Rats; Receptors, Calcium-Sensing; Up-Regulation; Vascular Remodeling; Vasoconstriction | 2016 |
Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Dihydropyridines; Disease Models, Animal; Diuretics; Drug Therapy, Combination; Enalapril; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Meta-Analysis as Topic; Nifedipine; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Sodium Chloride Symporter Inhibitors; Time Factors; Ventricular Dysfunction, Left | 2002 |
9 other study(ies) available for 1,4-dihydropyridine and Disease Models, Animal
| Article | Year |
|---|---|
Activation of the phosphatidylinositol 3-kinase pathway plays important roles in reduction of cerebral infarction by cilnidipine.
Topics: Animals; Brain; Cerebral Infarction; Dihydropyridines; Disease Models, Animal; Hypertension; Male; Phosphatidylinositol 3-Kinases; Rats, Sprague-Dawley; Signal Transduction | 2015 |
Dihydropyridine Derivatives Modulate Heat Shock Responses and have a Neuroprotective Effect in a Transgenic Mouse Model of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain; Cell Line, Tumor; Dendritic Spines; Dihydropyridines; Disease Models, Animal; Gene Expression Regulation; Heat-Shock Proteins; Humans; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Neuroblastoma; Neuroprotective Agents; Presenilin-1; tau Proteins | 2016 |
Memory-enhancing and brain protein expression-stimulating effects of novel calcium antagonist in Alzheimer's disease transgenic female mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Anti-Anxiety Agents; Blood-Brain Barrier; Calcium; Calcium Channel Blockers; Dihydropyridines; Disease Models, Animal; Female; GABAergic Neurons; Glutamate Decarboxylase; Gyrus Cinguli; Hippocampus; Male; Maze Learning; Memory; Mice; Mice, Transgenic; Neuronal Plasticity; Up-Regulation; Vesicular Inhibitory Amino Acid Transport Proteins | 2016 |
Pilot Trial of Intravenous Lipid Emulsion Treatment for Severe Nifedipine-Induced Shock.
Topics: Animals; Blood Glucose; Blood Pressure; Bradycardia; Calcium Channel Blockers; Dihydropyridines; Disease Models, Animal; Fat Emulsions, Intravenous; Female; Heart Arrest, Induced; Humans; Metabolome; Myocardial Contraction; Nifedipine; Pilot Projects; Shock; Swine; Tachycardia | 2016 |
Glucose-lowering in a db/db mouse model by dihydropyridine diacid glycogen phosphorylase inhibitors.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dihydropyridines; Disease Models, Animal; Enzyme Inhibitors; Glycogen Phosphorylase; Hypoglycemic Agents; Mice | 2003 |
Emergence of a R-type Ca2+ channel (CaV 2.3) contributes to cerebral artery constriction after subarachnoid hemorrhage.
Topics: Animals; Blood; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, R-Type; Cerebral Arteries; Cisterna Magna; Dihydropyridines; Diltiazem; Disease Models, Animal; Drug Resistance; Injections; Ion Transport; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nifedipine; omega-Agatoxin IVA; omega-Conotoxin GVIA; Patch-Clamp Techniques; Rabbits; Spider Venoms; Subarachnoid Hemorrhage; Vasoconstriction; Vasospasm, Intracranial | 2005 |
Effects of tetrandrine on left ventricle hypertrophy in deoxycorticosterone acetate-salt hypertensive rats.
Topics: Alkaloids; Animals; Antihypertensive Agents; Benzylisoquinolines; Binding, Competitive; Blood Pressure; Body Weight; Calcium; Desoxycorticosterone; Dihydropyridines; Disease Models, Animal; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Isradipine; Male; Mitochondria, Heart; Organ Size; Radioligand Assay; Random Allocation; Rats; Rats, Sprague-Dawley | 1995 |
Prevention of stroke and brain damage with calcium antagonists in animals.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Brain Damage, Chronic; Calcium Channel Blockers; Cerebrovascular Disorders; Dihydropyridines; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension; Isradipine; Male; Prognosis; Pyridines; Rats; Rats, Inbred SHR | 1991 |
Morphine withdrawal in cortical slices: suppression by Ca2+-channel inhibitors of abstinence-induced [3H]-noradrenaline release.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Cerebral Cortex; Dihydropyridines; Disease Models, Animal; In Vitro Techniques; Ion Channels; Morphine; Naloxone; Nimodipine; Norepinephrine; Rats; Substance Withdrawal Syndrome; Tritium | 1988 |